scott galloway glp 1 Galloway: AI and GLP-1 medications have the potential to be transformative The Truth About GLP-1s, Caring

From personal experience, the majority of patients whom I manage their T2DM treatment on these medications have expressed issues obtaining their product

Wilm B, et al

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

demonstrated that GLP-1RAs are associated with significantly lower risks of pneumonia and severe sepsis in patients with type 2 diabetes compared to dipeptidyl peptidase-4 inhibitors (DPP-4is)

Table 1 Published animal and human researches on the impact of GLP-1 on bone metabolism

GLP-1 medications mimic that hormone, working in your gut and brain to help regulate blood sugar, lower your appetite, and prolong feelings of fullness